1. Investment share capital:
Shares in group undertakings - £676 (2022 - £676)
Shares in UK associate - £510 (2022 - £510)
Shares in Poland associate - £290,255 (2022 - £281,763)
2. Investment Loans - £656,710
During the year funds were loaned from Biostatus Ltd to Biosuspensions Ltd, a company in which Biostatus Ltd owns 76% of the issued share capital. At the balance sheet date £297,359 (2022 - £274,223) was owed from Biosuspensions Ltd. This loan is not repayable until all other creditors have been repaid by Biosuspensions Ltd.
During the year funds were loaned from Biostatus Ltd to Oncotherics Ltd, a company in which Biostatus Ltd owns 39.84% of the issued share capital. At the balance sheet date £290,823 (2022 - £288,923) was owed from Oncotherics Ltd. The loan is not repayable until all other creditors have been repaid by Oncotherics Ltd.
At the balance sheet date £68,528 (2022 - £54,389) was owed from Biotherics Ltd, a company in which Biostatus Ltd owns 60% of the issued share capital. The loan is not repayable until all other creditors have been repaid by Biotherics Ltd.